AI and the Acceleration of Drug Development
Like it or not, artificial intelligence has likely impacted your daily life in some way. Whether you use ChatGPT to...
Read More biomarkers
How AI-Driven Eye Screening Could Personalize Treatment Pathways
Catherine Bornbaum, PhD, MBA, Chief Business Officer at RetiSpec, says retinal biomarkers and artificial intelligence can reshape diagnosis and care...
Read More 
The AI Advantage: Earlier, More Accurate OCT Insights
Have you ever finished writing a document and run a spelling and grammar check just to make sure you didn’t...
Read More 
Topcon Introduces IDHea to Advance Oculomics
LA JOLLA, Calif. — Topcon Healthcare, Inc. has officially introduced IDHea, Inc., the Institute for Digital Health. The new company...
Read More 
Altris AI’s Latest Tech Flags Pathologies, Biomarkers in OCT Scans
CHICAGO — Altris AI has introduced a new update to its technology that automatically flags OCT scans for popular biomarkers...
Read More 
Eye of the Storm: AI’s Disruption in Eye Care Impacts Medical Diagnostic Devices
Even in its early stage, the eye care industry recognizes artificial intelligence (AI) for its capacity to drive market advantages...
Read More